The HPAPI industry is expanding at a healthy rate due to development and manufacturing of drugs for anti-cancer and chronic disorders. Despite of challenges in designing multiproduct facilities, robust containment, safety & toxicology issues, there are many pharmaceutical firms coming up with their new research pipeline of drugs.
Head, Health Hazard Assessment, Novartis, Switzerland
Head Small Molecules Quality Operations, F.Hoffmann La Roche AG, Switzerland
Manufacturing Science & Technology (MS&T), Validation Head, Novartis, Switzerland
Senior Sourcing Manager, Genentech, USA
Managing Toxicologist, SafeBridge, UK
Principal Scientist, Boehringer-Ingelheim, Germany
Director, Scientific Affairs PCI Services, UK
Head, Health Hazard Assessment, Novartis, Switzerland
Platinium
Diamond
Gold
Silver
Sponsors & Exhibitors
Official Logistics Partner
For further information, please contact: events@marketsandmarkets.com
2nd Annual High Potent Medicines Conference
2nd Annual High Potent Medicines Conference will be held at the Dorint Hotels and Resorts
Dorint Hotels and Resorts
Main Taunus Zentrum
Frankfurt, Germany
About the Hotel
The Dorint Hotels & Resorts invite you to enjoy a relaxing, exciting, pampered, sporting and active holiday in the most attractive regions of Germany and Switzerland – on your own, as a couple or with the whole family. Whether our conference hotels in central location, our wellness hotels to enjoy and relax or our holiday apartments at the sea or in the countryside – you'll make a find at the Dorint Hotels & Resorts.
Richard Denk
